These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11453528)

  • 1. Study of zinc and growth hormone in sickle cell disease.
    Oliveira PM; Póvoa LC; Oliveira MH; Pfeiffer WC
    J Pediatr Endocrinol Metab; 2001 Jun; 14(6):773-9. PubMed ID: 11453528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc status in children and young adults with sickle cell disease.
    Abshire TC; English JL; Githens JH; Hambidge M
    Am J Dis Child; 1988 Dec; 142(12):1356-9. PubMed ID: 3195534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma zinc levels inversely correlate with vascular cell adhesion molecule-1 concentration in children with sickle cell disease.
    Kuvibidila SR; Sandoval M; Lao J; Velez M; Yu L; Ode D; Gardner R; Lane G; Warrier RP
    J Natl Med Assoc; 2006 Aug; 98(8):1263-72. PubMed ID: 16916123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry.
    Wajnrajch MP; Gertner JM; Huma Z; Popovic J; Lin K; Verlander PC; Batish SD; Giampietro PF; Davis JG; New MI; Auerbach AD
    Pediatrics; 2001 Apr; 107(4):744-54. PubMed ID: 11335753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc deficiency: a contributing factor of short stature in growth hormone deficient children.
    Siklar Z; Tuna C; Dallar Y; Tanyer G
    J Trop Pediatr; 2003 Jun; 49(3):187-8. PubMed ID: 12848213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone secretion and circulating insulin-like growth factor-I (IGF-I) and IGF binding protein-3 concentrations in children with sickle cell disease.
    Soliman AT; el Banna N; alSalmi I; De Silva V; Craig A; Asfour M
    Metabolism; 1997 Nov; 46(11):1241-5. PubMed ID: 9361679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study.
    Soliman AT; elZalabany M; Amer M; Ansari BM
    J Trop Pediatr; 1999 Feb; 45(1):23-30. PubMed ID: 10191589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone deficiency in patients with sickle cell disease and growth failure.
    Nunlee-Bland G; Rana SR; Houston-Yu PE; Odonkor W
    J Pediatr Endocrinol Metab; 2004 Apr; 17(4):601-6. PubMed ID: 15198291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc status of children with sickle cell disease: relationship to poor growth.
    Phebus CK; Maciak BJ; Gloninger MF; Paul HS
    Am J Hematol; 1988 Oct; 29(2):67-73. PubMed ID: 3189304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empty sella in short children with and without hypothalamic-pituitary abnormalities.
    Soliman AT; Darwish A; Asfour MG
    Indian J Pediatr; 1995; 62(5):597-603. PubMed ID: 10829929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum zinc and somatic growth in children with growth retardation.
    Fons C; Brun JF; Fussellier M; Cassanas G; Bardet L; Orsetti A
    Biol Trace Elem Res; 1992; 32():399-404. PubMed ID: 1375081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Dahlgren J; Bjarnason R; Rosberg S; Carlsson LM; Carlsson B; Albertsson-Wikland K
    Eur J Endocrinol; 1997 Oct; 137(4):387-95. PubMed ID: 9368507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma zinc status, growth, and maturation in children with sickle cell disease.
    Leonard MB; Zemel BS; Kawchak DA; Ohene-Frempong K; Stallings VA
    J Pediatr; 1998 Mar; 132(3 Pt 1):467-71. PubMed ID: 9544903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc, copper and iron and their interrelations in the growth of sickle cell patients.
    Pellegrini Braga JA; Kerbauy J; Fisberg M
    Arch Latinoam Nutr; 1995 Sep; 45(3):198-203. PubMed ID: 9332503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
    Charmandari E; Pincus SM; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc deficiency and blood lymphocyte function with sickle cell disease.
    Daeschner CW; Carpentieri U; Goldman AS; Haggard ME
    Scand J Haematol; 1985 Aug; 35(2):186-90. PubMed ID: 3876597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive effects of zinc supplementation on growth, GH, IGF1, and IGFBP3 in eutrophic children.
    Alves CX; Vale SH; Dantas MM; Maia AA; Franca MC; Marchini JS; Leite LD; Brandao-Neto J
    J Pediatr Endocrinol Metab; 2012; 25(9-10):881-7. PubMed ID: 23426817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid Function in Egyptian Children with Sickle Cell Anemia in Correlation with Iron Load.
    Hagag AA; El-Asy HM; Badraia IM; Hablas NM; El-Latif AEA
    Endocr Metab Immune Disord Drug Targets; 2019; 19(1):46-52. PubMed ID: 30207251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trace elements in sickle cell disease.
    Prasad AS; Ortega J; Brewer GJ; Oberleas D; Schoomaker EB
    JAMA; 1976 May; 235(22):2396-8. PubMed ID: 946645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.